Resveratrol administration prevents radiation-related changes in metabolic profiles of hearts 20 weeks after irradiation of mice with a single 2 Gy dose

Michalina Gramatyka; Piotr Widłak; Dorota Gabryś; Roland Kulik; Maria Sokół

doi:10.18388/abp.2020_5403

Resveratrol administration prevents radiation-related changes in metabolic profiles of hearts 20 weeks after irradiation of mice with a single 2 Gy dose

Michalina Gramatyka Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland https://orcid.org/0000-0002-9573-2479
Piotr Widłak Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland https://orcid.org/0000-0001-5099-4726
Dorota Gabryś Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland https://orcid.org/0000-0001-9096-2788
Roland Kulik Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
Maria Sokół Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland https://orcid.org/0000-0003-1611-8241

DOI: https://doi.org/10.18388/abp.2020_5403

Abstract

We aimed to evaluate whether resveratrol affects radiation-induced changes in metabolite profiles of the mouse heart. Hearts were irradiated in vivo with a single 2 Gy dose during the resveratrol administration and metabolite profiles of heart tissue were analyzed by the untargeted HR-MAS NMR approach twenty weeks after irradiation. The administration of resveratrol mitigated the radiation-induced decline in the content of choline-containing compounds and unsaturated lipids, which might reflect the stabilization of cell membrane structure against radiation-related damage. Results obtained with this mouse model suggest that the resveratrol supplementation may prevent metabolic changes related to radiation-induced damage in the heart.

pdf
html

Published

2020-12-17

Issue

Vol. 67 No. 4 (2020)

Section

Articles

Acta Biochimica Polonica is an OpenAccess quarterly and publishes four issues a year. All contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.